Shares of Precision Drilling (PDS) have gained 0.7% over the past four weeks to close the last trading session at $53.47, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $71.06 indicates a potential upside of 32.9%.The mean estimate comprises eight short-term price targets with a standard deviation of $9.08. While the lowest estimate of $55.76 indicates a 4.3% increase from the ...

Shares of Micron (MU) have gained 6.7% over the past four weeks to close the last trading session at $117.21, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $152.42 indicates a potential upside of 30%.The mean estimate comprises 33 short-term price targets with a standard deviation of $26.08. While the lowest estimate of $75.00 indicates a 36% decline from the current price lev ...

Arcutis Biotherapeutics, Inc. (ARQT) closed the last trading session at $15.63, gaining 1.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $22.63 indicates a 44.8% upside potential.The average comprises eight short-term price targets ranging from a low of $18.00 to a high of $29.00, with a standard deviation of $3.25. While the lowest estimate indicates an increase of 15.2% from ...

Uber Technologies (NASDAQ: UBER) has a bold new advocate in CNBC’s Jim Cramer, who believes the ridesharing giant could more than double in value.“I think Uber’s going to $200,” Cramer said during his “Mad Money” lightning round on July 23, calling the company a “cash flow juggernaut.” He urged investors to “go buy more here,” emphasizing that Uber’s business model makes it worth holding, even buying at current levels.The timing of his call is notable. When Cramer made those remarks, Uber was trading at $89 ...

Core Viewpoint - Gentherm (THRM) shows potential for further upside, with a mean price target of $40.6 indicating a 26.7% upside from its last trading price of $32.04 [1] Price Targets and Analyst Estimates - The mean estimate consists of five short-term price targets with a standard deviation of $6.91, suggesting variability in analyst predictions [2] - The lowest estimate of $35.00 indicates a 9.2% increase, while the highest estimate of $52.00 suggests a 62.3% increase [2] - A low standard deviation indicates a higher agreement among analysts regarding price movement [9] Earnings Estimates and Analyst Sentiment - Analysts have shown increasing optimism about THRM's earnings prospects, with a strong consensus in revising EPS estimates higher [11] - The Zacks Consensus Estimate for the current year has increased by 2.9% over the past month, with two estimates going higher and no negative revisions [12] - THRM holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] Caution on Price Targets - While price targets are often sought after, they can mislead investors, as empirical research shows they rarely indicate actual price movements [7][10] - Analysts may set overly optimistic price targets due to business incentives, which can inflate expectations [8]

Core Viewpoint - Amneal Pharmaceuticals (AMRX) shows potential for significant upside, with a mean price target of $11.75 indicating a 43.8% increase from the current price of $8.17 [1] Price Targets and Analyst Consensus - The average price target for AMRX ranges from a low of $11.00 to a high of $12.00, with a standard deviation of $0.5, suggesting a relatively tight clustering of estimates [2] - The lowest estimate indicates a 34.6% increase, while the highest points to a 46.9% upside [2] - Analysts' agreement on earnings estimates is strong, which supports the potential for stock price increases [4][11] Earnings Estimates and Zacks Rank - The Zacks Consensus Estimate for AMRX has increased by 1.1% due to one upward revision in earnings estimates over the past 30 days, with no negative revisions [12] - AMRX holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for upside [13] Caution on Price Targets - While price targets are a common metric, they should not be the sole basis for investment decisions due to historical inaccuracies in predicting actual stock movements [3][7][10] - Analysts may set overly optimistic price targets influenced by business relationships, which can lead to inflated expectations [8]

Core Viewpoint - Genmab A/S (GMAB) shows potential for significant upside, with a mean price target of $30.36 indicating a 40% increase from the current price of $21.69 [1] Price Targets and Analyst Consensus - The average price target consists of seven estimates ranging from $20.00 to $46.00, with a standard deviation of $8.82, indicating variability among analysts [2] - The lowest estimate suggests a decline of 7.8%, while the highest points to a 112.1% upside [2] - A low standard deviation indicates strong agreement among analysts regarding the stock's price direction [9] Earnings Estimates and Analyst Optimism - Analysts have shown growing optimism about GMAB's earnings prospects, as evidenced by upward revisions in EPS estimates [11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has increased by 7.4%, with two estimates moving higher and one lower [12] - GMAB holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate factors [13] Caution on Price Targets - While price targets are often sought after, they can mislead investors, as empirical research shows they rarely indicate actual price movements [7][10] - Analysts may set overly optimistic price targets due to business incentives, which can inflate expectations [8]

Core Viewpoint - Sky Harbour Group Corporation (SKYH) shows potential for significant upside, with a mean price target of $17.92 indicating a 76.9% increase from its current price of $10.13 [1] Price Targets and Analyst Estimates - The mean estimate consists of six short-term price targets with a standard deviation of $4.8, suggesting variability among analysts [2] - The lowest estimate of $14.00 indicates a 38.2% increase, while the highest estimate of $25.00 suggests a potential surge of 146.8% [2] - Analysts' price targets can often mislead investors, as empirical research indicates they rarely reflect actual stock price movements [7][10] Earnings Estimates and Analyst Agreement - There is strong agreement among analysts regarding SKYH's ability to report better earnings, which supports the potential for stock upside [4][11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has increased by 9.8%, with one estimate moving higher and no negative revisions [12] - SKYH holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates [13] Conclusion on Price Movement - While the consensus price target may not be a reliable indicator of the extent of potential gains, it does provide a useful guide for the direction of price movement [14]

Core Viewpoint - Ardmore Shipping (ASC) shows potential for upside based on Wall Street analysts' price targets, with a mean target of $13.17 indicating a 25.7% upside from the current price of $10.48 [1] Price Targets and Estimates - The average price target consists of three estimates ranging from a low of $12.50 to a high of $14.00, with a standard deviation of $0.76, suggesting a consensus among analysts [2] - The lowest estimate indicates a 19.3% increase, while the highest suggests a 33.6% upside [2] - Analysts' agreement on earnings estimates is a strong indicator of potential stock performance, with positive revisions correlating with price movements [4][11] Analyst Behavior and Price Target Reliability - Solely relying on price targets for investment decisions may not be prudent due to historical inaccuracies in analysts' predictions [3][7] - Analysts often set optimistic price targets influenced by business relationships, which can lead to inflated expectations [8] - A low standard deviation in price targets indicates strong agreement among analysts, which can serve as a starting point for further research [9] Earnings Estimates and Zacks Rank - ASC has seen a positive trend in earnings estimate revisions, with a 16.2% increase in the Zacks Consensus Estimate over the past 30 days [12] - The company holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] - While price targets may not be entirely reliable, the direction they imply can be a useful guide for potential stock movement [14]

Core Viewpoint - Kennedy-Wilson (KW) has shown a significant price increase of 11.3% over the past four weeks, with a mean price target of $9.9 indicating a potential upside of 32.7% from the current price of $7.46 [1] Price Targets and Analyst Consensus - The average price targets for KW range from a low of $7.70 to a high of $13.00, with a standard deviation of $2.76, suggesting variability in analyst estimates [2] - The lowest estimate indicates a 3.2% increase, while the highest suggests a 74.3% upside, highlighting the potential for significant price movement [2] - A low standard deviation among price targets indicates a high degree of agreement among analysts regarding the stock's price direction [9] Earnings Estimates and Market Sentiment - Analysts have shown increasing optimism about KW's earnings prospects, with a strong consensus on revising EPS estimates higher, which correlates with potential stock price increases [11] - The Zacks Consensus Estimate for the current year has risen by 245.5% over the past month, indicating positive sentiment among analysts [12] - KW holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, further supporting its potential upside [13] Caution on Price Targets - While price targets are commonly referenced by investors, they can often mislead, as empirical research shows that they rarely predict actual stock price movements accurately [7][10] - Analysts may set overly optimistic price targets due to business incentives, which can inflate expectations [8]